imatinib mesylate has been researched along with Parasitemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kesely, KR; Low, PS; Olupot-Olupot, P; Pantaleo, A; Turrini, FM | 1 |
Baer, K; Frevert, U; Kappe, SH; Mikolajczak, SA; Movila, A; Nacer, A | 1 |
2 other study(ies) available for imatinib mesylate and Parasitemia
Article | Year |
---|---|
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia.
Topics: Animals; Erythrocytes; Imatinib Mesylate; Parasitemia; Plasmodium falciparum; Protein-Tyrosine Kinases | 2016 |
Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Topics: Animals; Benzamides; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Imatinib Mesylate; Lipopolysaccharide Receptors; Lymphocyte Function-Associated Antigen-1; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neuroimmunomodulation; Parasitemia; Piperazines; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Propylene Glycols; Pyrimidines; Sphingosine | 2012 |